Survival of the fittest: The longevity of Olympic medalists in the modern era

More Information

Olympians live longer than the general population research from the University of Melbourne and published in the British Medical Journal today, has found.

The study found Olympic medalists live an average of 2.8 years longer than the general population, regardless of country of origin, colour of medal won, or type of sport played.

Researchers compared life expectancy among 15,174 Olympic athletes who won medals between 1896 and 2010 with general population groups matched by country, age, sex, and year of birth.

All medalists lived an average of 2.8 years longer - a significant survival advantage over the general population in eight out of the nine countries studied. Australian athletes were included in this group of nine countries and had similar survival advantages to other countries.

Gold, silver and bronze medalists enjoyed roughly the same survival advantage, as did medalists in both endurance and mixed sports. Medalists in power sports such as gymnastics and tennis had a smaller, but still significant, advantage over the general population.

Lead author Professor Philip Clarke said that their study was not designed to determine why Olympic athletes live longer. "There are many possible explanations including genetic factors, physical activity, healthy lifestyle, and the wealth and status that come from international sporting glory."

“Perhaps the one thing those of us who do not make the Olympic team can do to increase our life expectancy is to undertake regular exercise. This has been shown to decrease the risk of big killers like Type 2 Diabetes.”

Related content in Medicine and Health Science

The Melbourne Healthcare Partners Advanced Health Research and Translation Centre, coordinated by Melbourne Health, has been recognised as one of the world’s best for using medical research to improve patient care by the National Health and Medical Research Council (NHMRC)

Patients suffering from cancer, neurological conditions and infectious diseases will benefit significantly from the most recent round of research funding from the Federal Government’s National Health and Medical Research Council (NHMRC).